Veterinary Medicines

Poulvac IB primer

Not authorised
  • Avian infectious bronchitis virus, strain D274, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Download as PDF

Product identification

Medicine name:
Poulvac IB primer
Active substance:
  • Avian infectious bronchitis virus, strain D274, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, strain D274, Live
    1000.00
    unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    1000.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8446
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/02/2022
Download